Nuchal translucency measurements in consecutive normal pregnancies. Is there a predisposition to increased levels?

被引:6
作者
Maymon, R [1 ]
Padoa, A
Dreazen, E
Herman, A
机构
[1] Assaf Harofeh Med Ctr, Dept Obstet & Gynecol, IL-70300 Zerifin, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
nuchal translucency; subsequent pregnancy; Down syndrome screening;
D O I
10.1002/pd.399
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective The current study aims to assess the relative risk of isolated increased nuchal translucency (NT) in consecutive normal pregnancies. Methods A retrospective search of the fetal medicine unit database in which NT assessment was conducted. Only singleton fetuses with an unremarkable pregnancy outcome were included in this study. The repeated NT either at a threshold of >2.5 mm or greater than or equal to95th centile of the normal range for various CRLs (2 mm at a CRL less than or equal to44 mm to 2.85 mm at CRLs 83-84 mm) was assessed. Pearson's correlation was applied to investigate any correlation between a log,, NT obtained in two consecutive pregnancies. The chance of an increased NT in the first pregnancy followed by similar results in the subsequent one was assessed using Fisher's exact test. Results Ninety-two pregnant women with two consecutive normal pregnancies were identified. There was a highly significant correlation between the log,, NT values measured in the consecutive pregnancies (r = 0.38: p < 0.001). The relative risk of an isolated NT greater than or equal to2.5 mm in the first pregnancy to be followed by a similar finding in the subsequent one was 18.21 (95% confidence interval [Cl]: 3.62-61.55). The relative risk of an isolated NT greater than or equal to95th centile in the first pregnancy to be followed by a similar result in the subsequent one was 21 (95% Cl: 4.53-97.44). Conclusion The current results indicate a significant correlation of NT values in consecutive unaffected pregnancies. There also was a predisposition for a repeated isolated increased NT in subsequent pregnancies. Additional series and more information are needed before firm conclusions can be made. Copyright (C) 2002 John Wiley Sons. Ltd.
引用
收藏
页码:759 / 762
页数:4
相关论文
共 30 条
[21]  
2-L
[22]  
Spencer K, 1997, PRENATAL DIAG, V17, P39, DOI 10.1002/(SICI)1097-0223(199701)17:1<39::AID-PD35>3.0.CO
[23]  
2-N
[24]   Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnancies [J].
Spencer, K .
PRENATAL DIAGNOSIS, 2001, 21 (06) :445-447
[25]  
Spong CY, 1999, PRENATAL DIAG, V19, P337, DOI 10.1002/(SICI)1097-0223(199904)19:4<337::AID-PD553>3.0.CO
[26]  
2-4
[27]   Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome [J].
Thilaganathan, B ;
Slack, A ;
Wathen, NC .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 10 (04) :261-264
[28]  
Wald N J, 1997, J Med Screen, V4, P181
[29]  
WALD NJ, 1981, LANCET, V1, P1103
[30]  
Wax J R, 2000, J Matern Fetal Med, V9, P161, DOI 10.3109/14767050009020521